Search Within

Ana Alarcon Tomas

  1. "Survivorship Research"
Formats
  1. Meeting Abstract (25)
  2. Journal Article (17)
  3. Research Letter (2)
  4. Correspondence (1)
Groups
  1. Bone Marrow Transplant (45)
  2. Center for Hematologic Malignancies (45)
  3. Department of Medicine (45)
  4. Hematologic Malignancies, Division of (45)
  5. Survivorship Research (45)
  6. CTCR Scholars (42)

More Groups

People
  1. Gunjan Shah (45)
  2. Miguel-Angel Perales (45)
  3. Michael Scordo (42)
  4. Roni Shouval (41)
  5. Maria Palomba (39)
  6. Parastoo Dahi (39)

More People

Years
  1. 2025 (3)
  2. 2024 (5)
  3. 2023 (18)
  4. 2022 (11)
  5. 2021 (5)
  6. 2020 (2)

More Years

Publications
  1. Blood (18)
  2. Transplantation and Cellular Therapy (6)
  3. Blood Advances (4)
  4. Bone Marrow Transplantation (3)
  5. Hematological Oncology (2)
  6. International Journal of Radiation Oncology, Biology, Physics (2)

More Publications

Publishers
  1. American Society of Hematology (22)
  2. Elsevier Inc. (8)
  3. Nature Publishing Group (7)
  4. Wiley Blackwell (2)
  5. American Association for Cancer Research (1)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (45)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells
    Journal Article

    Pennisi, M.; Sanchez-Escamilla, M.; Flynn, J. R.; Shouval, R.; Alarcon Tomas, A.; Silverberg, M. L.; Batlevi, C.; Brentjens, R. J.; Dahi, P. B.; Devlin, S. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation
    Research Letter

    Lin, R. J.; Baser, R. E.; Elko, T. A.; Korc-Grodzicki, B.; Shahrokni, A.; Maloy, M. A.; Young, J. W.; Tamari, R.; Shah, G. L.; Shaffer, B. C.; more...
    Bone Marrow Transplantation (2021)

    Fulltext@MSK | Save
  • Clinical impact of bridging therapy prior to commercial chimeric antigen receptor (CAR) T-cell therapies for relapsed/refractory lymphomas
    Meeting Abstract

    Imber, B. S.; Perales, M. A.; Flynn, J.; Ruiz, J. D.; Devlin, S.; Alarcon Tomas, A.; Hajj, C.; Batlevi, C. L.; Dahi, P. B.; Lin, R. J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation
    Journal Article

    Peled, J. U.; Gomes, A. L. C.; Devlin, S. M.; Littmann, E. R.; Taur, Y.; Sung, A. D.; Weber, D.; Hashimoto, D.; Slingerland, A. E.; Slingerland, J. B.; more...
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save
  • Pre-transplant fecal microbial diversity independently predicts critical illness after hematopoietic cell transplantation
    Meeting Abstract

    Adhi, F. I.; Littmann, E. R.; Taur, Y.; Maloy, M. A.; Markey, K. A.; Fontana, E.; Amoretti, L. A.; Wright, R.; Sanchez-Escamilla, M.; Castillo Flores, N.; more...
    Blood (2019)

    Fulltext@MSK | Save